ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 679095 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 679095; 2) Community: the network communities that were significantly associated with the response to NSC 679095; 3) Molecule: the relationships between components within communities and NSC 679095; 4) MDR: the compounds that were significantly associated with the NSC 679095.

NSC Compound Enrichment Correlation
NSC 111533 Methoxycamptothecin 0.0376362543535812 0.091461435
NSC 112152 2H,4aH-1,4,5-Trioxadicyclopent[a,hi]indene-7-carboxylic acid, 3-ethylidene-3,3a,7a,9b-tetrahydro-2-oxo-, methyl ester, [3aS-(3E,3a.alpha.,4a.beta.,7a.beta.,9aR*,9b.beta.)]- (9CI) 0.0376362543535812 -0.28579062
NSC 135371 Null 0.0376362543535812 -0.43661825
NSC 269599 Stannane, chlorohydroxydiphenyl- 0.0376362543535812 -0.30564784
NSC 314622 Indenoisoquinoline derivative 0.0376362543535812 -0.060573058
NSC 357288 LIATRIS LAEVIGATA LACTONE #2 0.0376362543535812 -0.41039851
NSC 374028 Camptothecin Derivative 0.0376362543535812 -0.016126704
NSC 38643 Lenamycin 0.0376362543535812 -0.36699583
NSC 603553 2-Propen-1-one, 2-[(dimethylamino)methyl]-1-(4-methoxy phenyl)-, hydrochloride 0.0376362543535812 -0.35184079
NSC 623599 4-Methyl-1,2,4-benzotriazin-3(4H)-imine 1-oxide, hydrochloride 0.0376362543535812 -0.42910083
Total:55  Current:38    [First] [Prev] [Next] [Last]